Pardeep Nijhawan - 03 Aug 2026 Form 4 Insider Report for Edesa Biotech, Inc. (EDSA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
04 Aug 2026, 17:02:08 UTC
Prior SEC filing
02 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Peter J. Weiler, Attorney-in-Fact for Pardeep Nijhawan

Key filing fact

Pardeep Nijhawan filed Form 4 for Edesa Biotech, Inc. (EDSA) on 04 Aug 2026.

Key facts

  • This page summarizes Pardeep Nijhawan's Form 4 filing for Edesa Biotech, Inc. (EDSA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 04 Aug 2026, 17:02.

Change

  • Previous filing in this sequence was filed on 02 Jul 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001777962 Primary reporting owner

Nijhawan Pardeep

Relationship
Chief Executive Officer, Director, 10%+ Owner
Address
C/O EDESA BIOTECH INC., 100 SPY COURT, MARKHAM, ONTARIO, CANADA
Signature
/s/ Peter J. Weiler, Attorney-in-Fact for Pardeep Nijhawan
Signature date
04 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EDSA transaction

Common Shares

Award

Transaction value
Shares
+5,324
Change %
+0.6%
Price
$0.000000*
Shares after
893,386
Date
03 Aug 2026
Ownership
Direct
Footnotes
F1
EDSA holding

Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
402,702
Date
03 Aug 2026
Ownership
Held by Pardeep Nijhawan Medicine Professional Corporation
Footnotes
F2
EDSA holding

Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
32,609
Date
03 Aug 2026
Ownership
Held by The New Nijhawan Family Trust 2015
Footnotes
F3
EDSA holding

Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
32,013
Date
03 Aug 2026
Ownership
Held by The Digestive Health Clinic Inc.
Footnotes
F2
EDSA holding

Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
53,104
Date
03 Aug 2026
Ownership
Held by 1968160Ontario Inc.
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan.

Footnote F2

Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Footnote F3

Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .